Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1890: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis

View through CrossRef
Abstract Calcitonin & calcitonin receptor axis (CT-CTR) expression is increased in prostate cancer & its levels positively correlate with Gleason grade of prostate cancer. Moreover, activation of CT-CTR autocrine axis promotes several processes with tumor progression such as, tumor growth, invasion, angiogenesis, chemoresistance & metastasis. However, the role of CT-CTR axis in carcinogenesis process has not been investigated. To examine the role of CT-CTR axis in prostate carcinogenesis we examined the impact of CTR deficiency on T-antigen-induced prostate tumorigeneses in transgenic mice. We achieved this by cross-breading CTR-knockout mice with LPB-Tag mice (the transgenic mice that uses long Probasin promotor for prostate-specific expression of Tag T-antigen). The cross-breeding of these two transgenic mice yielded four different groups of mice with the following genotypes 1. Control (which lacked both transgenes), 2. CTRKO (only CTRKO transgene), 3. LPB-Tag (contained LPB-Tag transgene), & 4. CTRKO-LPB-Tag (expressed Both CTRKO & LPB-Tag transgenes). The growth of these mice were monitored until they reached the age of 90 days. The mice were sacrificed, the prostates were collected, fixed & evaluated by histology & immunohistochemistry. The results suggest that the mice of all groups developed normally with the exception of LPB-Tag group which displayed slower growth & the presence of prostatic tumors at the time of necropsy. Although all LPB-Tag mice displayed all prostate tumors, as expected wild type & CTRKO mice did not display change in the size or mass of prostates. Subsequently, H&E histology as well as Ki67 staining confirmed that all LPB-Tag mice displayed well-developed prostatic adenocarcinoma, all CTRKO-LPB-Tag displayed no presence of tumor with the exception of occasional presence of HGPIN. Since our earlier studies have shown that CTR induced epithelial-to-mesenchymal transition (EMT) in prostate cancer cell lines, we also examined the expression of two epithelial markers, ZO-1 & E-cadherin, & two mesenchymal markers, fibronectin & vimentin. The results suggest that prostates of the three groups ( WT, CTRKO, LPB-Tag-CTRKO) displayed higher epithelial markers expression with a remarkably lower expression of mesenchymal markers when compared with those of LPB-Tag group. This was further substantiated by the expression of EMT markers such as snail & N-cadherin. In conclusion, this study shows that the CTR deficiency inhibits prostate carcinogenesis in LPB-Tag mice without reducing T-antigen expression or causing any other apparent harmful side effects. This work was supported by NIH grant CA096534. Citation Format: Afaf Aldahish, Arvind Thakkar, Girish V. Shah. Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1890.
American Association for Cancer Research (AACR)
Title: Abstract 1890: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis
Description:
Abstract Calcitonin & calcitonin receptor axis (CT-CTR) expression is increased in prostate cancer & its levels positively correlate with Gleason grade of prostate cancer.
Moreover, activation of CT-CTR autocrine axis promotes several processes with tumor progression such as, tumor growth, invasion, angiogenesis, chemoresistance & metastasis.
However, the role of CT-CTR axis in carcinogenesis process has not been investigated.
To examine the role of CT-CTR axis in prostate carcinogenesis we examined the impact of CTR deficiency on T-antigen-induced prostate tumorigeneses in transgenic mice.
We achieved this by cross-breading CTR-knockout mice with LPB-Tag mice (the transgenic mice that uses long Probasin promotor for prostate-specific expression of Tag T-antigen).
The cross-breeding of these two transgenic mice yielded four different groups of mice with the following genotypes 1.
Control (which lacked both transgenes), 2.
CTRKO (only CTRKO transgene), 3.
LPB-Tag (contained LPB-Tag transgene), & 4.
CTRKO-LPB-Tag (expressed Both CTRKO & LPB-Tag transgenes).
The growth of these mice were monitored until they reached the age of 90 days.
The mice were sacrificed, the prostates were collected, fixed & evaluated by histology & immunohistochemistry.
The results suggest that the mice of all groups developed normally with the exception of LPB-Tag group which displayed slower growth & the presence of prostatic tumors at the time of necropsy.
Although all LPB-Tag mice displayed all prostate tumors, as expected wild type & CTRKO mice did not display change in the size or mass of prostates.
Subsequently, H&E histology as well as Ki67 staining confirmed that all LPB-Tag mice displayed well-developed prostatic adenocarcinoma, all CTRKO-LPB-Tag displayed no presence of tumor with the exception of occasional presence of HGPIN.
Since our earlier studies have shown that CTR induced epithelial-to-mesenchymal transition (EMT) in prostate cancer cell lines, we also examined the expression of two epithelial markers, ZO-1 & E-cadherin, & two mesenchymal markers, fibronectin & vimentin.
The results suggest that prostates of the three groups ( WT, CTRKO, LPB-Tag-CTRKO) displayed higher epithelial markers expression with a remarkably lower expression of mesenchymal markers when compared with those of LPB-Tag group.
This was further substantiated by the expression of EMT markers such as snail & N-cadherin.
In conclusion, this study shows that the CTR deficiency inhibits prostate carcinogenesis in LPB-Tag mice without reducing T-antigen expression or causing any other apparent harmful side effects.
This work was supported by NIH grant CA096534.
Citation Format: Afaf Aldahish, Arvind Thakkar, Girish V.
Shah.
Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA.
Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1890.

Related Results

Diagnostic Accuracy of Prostatic Specific Antigen Densityin Different Prostatic Disorders
Diagnostic Accuracy of Prostatic Specific Antigen Densityin Different Prostatic Disorders
Objective: To determine the diagnostic accuracy of PSA density in Prostate Cancer, Benign Prostatic Hyperplasia (BPH) and Prostatitis, taking biopsy as the gold standard. Stu...
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Abstract Background Recently, most studies on the spatial distribution of the prostate cancer are based on the samples confirmed by transrectal prostate biopsy (TRBx), whic...
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Introduction: Prostate cancer is a prevalent and potentially lethal malignancy affecting men worldwide. To enhance early detection and accurate risk stratification, various diagnos...
Predictive value of prostate calcification for future cancer occurrence: a retrospective long-term follow-up cohort study
Predictive value of prostate calcification for future cancer occurrence: a retrospective long-term follow-up cohort study
Objective: Although prostate calcification is often identified on pelvic CT images, calcification itself is usually not considered clinically significant. A recent histological stu...
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
Introduction: To increase the detection rate of prostate cancer inrecent years, we examined the increase in the number of corestaken at initial prostate biopsy. We hypothesized tha...
Predictive value of PSA density in the diagnosis of prostate cancer in lebanese men
Predictive value of PSA density in the diagnosis of prostate cancer in lebanese men
Objective: Being the second most common cancer in men, prostate cancer detection relies on laboratory tests, imaging, and surgical procedures, although biopsy remains the mainstay ...
Preliminary study on miRNA in prostate cancer
Preliminary study on miRNA in prostate cancer
Abstract Objective To screen for miRNAs differentially expressed in prostate cancer and prostate hyperplasia tissues and to validate their association with prostate cancer...
An update on the serum and urinary biomarkers in diagnosing prostate cancer
An update on the serum and urinary biomarkers in diagnosing prostate cancer
Introduction: In terms of global health issues, prostate cancer ranks high. The prostate cancer diagnosis rate is on the rise in India, where it ranks as the second most frequent m...

Back to Top